HUSSMAN STRATEGIC ADVISORS, INC.
Position in UTHR — UNITED THERAPEUTICS Corp
CIK 1179475
ELLICOTT CITY, MD
Position in UTHR
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,137,843
-$3,086,202 QoQ
Shares Held
2,100
-85.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#448
of 870 holders
Holding Since
Sep 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HUSSMAN STRATEGIC ADVISORS, INC. holds $14,720,685 across 7 Drug Manufacturers - Specialty & Generic names. UTHR ranks #6 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
27,300 | $4,601,142 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
31,500 | $2,607,570 | |
| 3 | ALKS |
Alkermes plc.
|
42,000 | $2,200,800 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
210,000 | $2,100,000 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
42,000 | $1,318,800 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
2,100 | $1,137,843 | |
| 7 | ZTS |
Zoetis Inc.
|
10,500 | $754,530 |
All Filings in UTHR
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,137,843 | 2,100 | Shares | Sole | 2026-08-03 | |
| 2025-06-30 | $4,224,045 | 14,700 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,884,202 | 12,600 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,963,856 | 8,400 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $2,257,605 | 6,300 | Shares | Sole | 2024-11-01 | |
| 2023-06-30 | $2,052,975 | 9,300 | Shares | Sole | 2023-08-03 | |
| 2021-12-31 | $561,808 | 2,600 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $572,198 | 3,100 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $1,291,752 | 7,200 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,806,516 | 10,800 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $1,548,258 | 10,200 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $2,575,500 | 25,500 | Shares | Sole | 2020-11-02 | |
| No filing history on record for this holder in this stock. | ||||||